Fina Climent

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 80 publications

Ocular adnexa follicular lymphoma: clinicopathological study of 23 patients.

Ocular adnexa follicular lymphoma: clinicopathological study of 23 patients.

Journal: Virchows Archiv : an international journal of pathology

Published: November 30, 2025

A prospective cohort study for characterization and predictive factors of long-term POST-COVID interstitial changes.

A prospective cohort study for characterization and predictive factors of long-term POST-COVID interstitial changes.

Journal: Respiratory research

Published: June 28, 2025

Skin manifestations uncover underlying Follicular helper T-cell lymphoma, angioimmunoblastic-type in an immunosuppressed patient.

Skin manifestations uncover underlying Follicular helper T-cell lymphoma, angioimmunoblastic-type in an immunosuppressed patient.

Journal: Virchows Archiv : an international journal of pathology

Published: May 15, 2025

The role of miR-150-5p/E2F3/survivin axis in the pathogenesis of plasmablastic lymphoma and its therapeutic potential.

The role of miR-150-5p/E2F3/survivin axis in the pathogenesis of plasmablastic lymphoma and its therapeutic potential.

Journal: Blood advances

Published: February 10, 2025

European Organisation for Research and Treatment of Cancer, United States Cutaneous Lymphoma Consortium and International Society for Cutaneous Lymphomas consensus recommendations for management and treatment of cutaneous lymphoproliferative disorders.

European Organisation for Research and Treatment of Cancer, United States Cutaneous Lymphoma Consortium and International Society for Cutaneous Lymphomas consensus recommendations for management and treatment of cutaneous lymphoproliferative disorders.

Journal: The British journal of dermatology

Published: January 25, 2025

Systemic mastocytosis with an associated myeloid neoplasm: Report from the XVI European Bone Marrow Working Group Course and Workshop, Barcelona 2023.

Systemic mastocytosis with an associated myeloid neoplasm: Report from the XVI European Bone Marrow Working Group Course and Workshop, Barcelona 2023.

Journal: American journal of clinical pathology

Published: December 06, 2024

Bridging clinicopathologic features and genetics in follicular lymphoma: Towards enhanced diagnostic accuracy and subtype differentiation.

Bridging clinicopathologic features and genetics in follicular lymphoma: Towards enhanced diagnostic accuracy and subtype differentiation.

Journal: Human pathology

Published: October 01, 2024

Early-stage mycosis fungoides: searching for biomarkers associated with advanced-stage progression.

Early-stage mycosis fungoides: searching for biomarkers associated with advanced-stage progression.

Journal: The British journal of dermatology

Published: August 20, 2024

Multiplex spatial analysis reveals increased CD137 expression and m-MDSC neighboring tumor cells in refractory classical Hodgkin Lymphoma.

Multiplex spatial analysis reveals increased CD137 expression and m-MDSC neighboring tumor cells in refractory classical Hodgkin Lymphoma.

Journal: Oncoimmunology

Published: August 13, 2024

Large B-cell lymphomas with CCND1 rearrangement have different immunoglobulin gene breakpoints and genomic profile than mantle cell lymphoma.

Large B-cell lymphomas with CCND1 rearrangement have different immunoglobulin gene breakpoints and genomic profile than mantle cell lymphoma.

Journal: Blood cancer journal

Published: July 09, 2024

Characterizing Nodal Gamma-Delta T-Cell Lymphoma: Clinicopathological and Molecular Insights.

Characterizing Nodal Gamma-Delta T-Cell Lymphoma: Clinicopathological and Molecular Insights.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Published: July 04, 2024

Neoadjuvant sunitinib plus exemestane in post-menopausal women with hormone receptor-positive/HER2-negative early-stage breast cancer (SUT_EXE-08): a phase I/II trial.

Neoadjuvant sunitinib plus exemestane in post-menopausal women with hormone receptor-positive/HER2-negative early-stage breast cancer (SUT_EXE-08): a phase I/II trial.

Journal: Scientific reports

Published: June 15, 2024

Showing 1-12 of 80

Last Updated: 09/26/2026